Niraparib generic Niraparib is prescribed as a maintenance treatment in adult patients with recurrent epithelial ovarian cancer , fallopian tube cancer, or primary peritoneal cancer who show a complete or partial response to platinum-based chemotherapy. Niraparib works by inhibiting the PARP (poly ADP-ribose polymerase) activity. It results in the formation of PARP-DNA complexes leading to the damage of DNA and tumor cell death. It benefits by improving the patient's progression-free survival and should be given only by the medical specialist who is an expert in handling anti-cancer medicines.
More Info about Niraparib